tiprankstipranks
Advertisement
Advertisement

IRON Stock Latest News

3 Best Stocks to Buy Today, 3/30/2026, According to Top Analysts
Market News3 Best Stocks to Buy Today, 3/30/2026, According to Top Analysts
10d ago
IRD
GENI
Disc Medicine completes enrollment in APOLLO trial
PremiumThe Fly
Disc Medicine completes enrollment in APOLLO trial
14d ago
IRON
FDA review process for accelerated approval narrows, less predictable, WSJ says
PremiumThe Fly
FDA review process for accelerated approval narrows, less predictable, WSJ says
1M ago
CAPR
IRON
Disc Medicine price target raised to $79 from $78 at Wells Fargo
PremiumThe Fly
Disc Medicine price target raised to $79 from $78 at Wells Fargo
1M ago
IRON
Disc Medicine Implements Restructuring Following FDA Response
PremiumCompany Announcements
Disc Medicine Implements Restructuring Following FDA Response
1M ago
8K
IRON
Disc Medicine price target lowered to $83 from $114 at Truist
PremiumThe FlyDisc Medicine price target lowered to $83 from $114 at Truist
1M ago
IRON
Disc Medicine price target raised to $111 from $110 at Stifel
Premium
The Fly
Disc Medicine price target raised to $111 from $110 at Stifel
1M ago
IRON
Disc Medicine: Bitopertin’s De-Risked Path to Approval Supports Buy Rating
Premium
Ratings
Disc Medicine: Bitopertin’s De-Risked Path to Approval Supports Buy Rating
1M ago
IRON
Disc Medicine: Strong Cash Runway and Bitopertin Upside Support Buy Rating Despite Regulatory Setbacks
PremiumRatings
Disc Medicine: Strong Cash Runway and Bitopertin Upside Support Buy Rating Despite Regulatory Setbacks
1M ago
IRON
Disc Medicine reports FY25 EPS ($6.01) vs ($3.96) last year
PremiumThe Fly
Disc Medicine reports FY25 EPS ($6.01) vs ($3.96) last year
1M ago
IRON
Disc Medicine’s RALLY-IBD Trial Puts a Spotlight on Anemia Relief in IBD Patients
PremiumCompany Announcements
Disc Medicine’s RALLY-IBD Trial Puts a Spotlight on Anemia Relief in IBD Patients
1M ago
IRON
Disc Medicine price target lowered to $88 from $110 at Wedbush
PremiumThe Fly
Disc Medicine price target lowered to $88 from $110 at Wedbush
2M ago
IRON
Disc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald
PremiumThe FlyDisc Medicine price target lowered to $125 from $153 at Cantor Fitzgerald
2M ago
IRON
Disc Medicine price target lowered to $75 from $120 at Morgan Stanley
Premium
The Fly
Disc Medicine price target lowered to $75 from $120 at Morgan Stanley
2M ago
IRON
Disc Medicine price target lowered to $110 from $125 at Stifel
Premium
The Fly
Disc Medicine price target lowered to $110 from $125 at Stifel
2M ago
IRON
Disc Medicine price target lowered to $100 from $120 at BMO Capital
PremiumThe Fly
Disc Medicine price target lowered to $100 from $120 at BMO Capital
2M ago
IRON
Disc Medicine Addresses FDA Rejection of Bitopertin Filing
PremiumCompany Announcements
Disc Medicine Addresses FDA Rejection of Bitopertin Filing
2M ago
8K
IRON
Disc Medicine: Long‑Term Value Intact as Bitopertin Shifts to Lower‑Risk Traditional Approval Path
PremiumRatings
Disc Medicine: Long‑Term Value Intact as Bitopertin Shifts to Lower‑Risk Traditional Approval Path
2M ago
IRON
Disc Medicine move down Friday ‘fair’ after bitopertin CRL, says Wells Fargo
PremiumThe Fly
Disc Medicine move down Friday ‘fair’ after bitopertin CRL, says Wells Fargo
2M ago
IRON
Disc Medicine Receives FDA Complete Response on Bitopertin
PremiumCompany AnnouncementsDisc Medicine Receives FDA Complete Response on Bitopertin
2M ago
8K
IRON
Disc Medicine off lows after saying FDA issue ‘readily addressable’
Premium
The Fly
Disc Medicine off lows after saying FDA issue ‘readily addressable’
2M ago
IRON
Disc Medicine down 32% to $49 after confirming rejection letter from FDA
Premium
The Fly
Disc Medicine down 32% to $49 after confirming rejection letter from FDA
2M ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >